biotin has been researched along with ganglio-n-triaosylceramide in 2 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (ganglio-n-triaosylceramide) | Trials (ganglio-n-triaosylceramide) | Recent Studies (post-2010) (ganglio-n-triaosylceramide) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 50 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hakomori, S; Matsuura, H; Okada, Y | 1 |
| Bierfreund, U; Childs, RA; Feizi, T; Hoffmann, A; Lemm, T; Sandhoff, K; Uhlhorn-Dierks, G; Yuen, CT | 1 |
2 other study(ies) available for biotin and ganglio-n-triaosylceramide
| Article | Year |
|---|---|
Inhibition of tumor cell growth by aggregation of a tumor-associated glycolipid antigen: a close functional association between gangliotriaosylceramide and transferrin receptor in mouse lymphoma L-5178Y.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Avidin; Biotin; Culture Media; Gangliosides; Glycosphingolipids; Killer Cells, Natural; Lymphoma; Mice; Receptors, Cell Surface; Receptors, Transferrin; Transferrin | 1985 |
Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay.
Topics: Biotin; Cells, Cultured; Citrates; Fibroblasts; G(M2) Activator Protein; Gangliosides; Gangliosidoses; Glycosphingolipids; Humans; Hydrogen-Ion Concentration; Infant; Protein Binding; Proteins; Recombinant Proteins; Sandhoff Disease; Sodium Chloride; Tay-Sachs Disease | 1999 |